COVID-19 has rapidly become a major health emergency worldwide. Patients with IBD are at increased risk of infection, especially when they have active disease and are taking immunosuppressive therapy. The characteristics and outcomes of COVID-19 in patients with IBD remain unclear.
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study
Bezzio, Cristina;Danese, Silvio;Armuzzi, Alessandro;Fiorino, Gionata
2020-01-01
Abstract
COVID-19 has rapidly become a major health emergency worldwide. Patients with IBD are at increased risk of infection, especially when they have active disease and are taking immunosuppressive therapy. The characteristics and outcomes of COVID-19 in patients with IBD remain unclear.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
gutjnl-2020-321411.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Dominio pubblico
Dimensione
482.16 kB
Formato
Adobe PDF
|
482.16 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
